These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33971027)

  • 1. Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo.
    Porta S; Xu Y; Lehr T; Zhang B; Meymand E; Olufemi M; Stieber A; Lee EB; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1033-1049. PubMed ID: 33971027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo.
    Porta S; Xu Y; Restrepo CR; Kwong LK; Zhang B; Brown HJ; Lee EB; Trojanowski JQ; Lee VM
    Nat Commun; 2018 Oct; 9(1):4220. PubMed ID: 30310141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
    Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
    Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice.
    Walker AK; Tripathy K; Restrepo CR; Ge G; Xu Y; Kwong LK; Trojanowski JQ; Lee VM
    Hum Mol Genet; 2015 Dec; 24(25):7241-54. PubMed ID: 26476406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
    Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
    Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.
    Neumann M; Lee EB; Mackenzie IR
    Adv Exp Med Biol; 2021; 1281():201-217. PubMed ID: 33433877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
    Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
    Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD.
    Chevalier E; Audrain M; Ratnam M; Ollier R; Fuchs A; Piorkowska K; Pfeifer A; Kosco-Vilbois M; Seredenina T; Afroz T
    Acta Neuropathol Commun; 2024 Oct; 12(1):156. PubMed ID: 39363348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
    Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
    Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
    Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
    Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.
    Laferrière F; Maniecka Z; Pérez-Berlanga M; Hruska-Plochan M; Gilhespy L; Hock EM; Wagner U; Afroz T; Boersema PJ; Barmettler G; Foti SC; Asi YT; Isaacs AM; Al-Amoudi A; Lewis A; Stahlberg H; Ravits J; De Giorgi F; Ichas F; Bezard E; Picotti P; Lashley T; Polymenidou M
    Nat Neurosci; 2019 Jan; 22(1):65-77. PubMed ID: 30559480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes.
    Tomé SO; Vandenberghe R; Ospitalieri S; Van Schoor E; Tousseyn T; Otto M; von Arnim CAF; Thal DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):61. PubMed ID: 32349792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.
    Josephs KA; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Perkerson RB; Matchett BJ; Jack CR; Knopman DS; Petersen RC; Parisi JE; Petrucelli L; Baker M; Rademakers R; Whitwell JL; Dickson DW
    Acta Neuropathol; 2019 Feb; 137(2):227-238. PubMed ID: 30604226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing post-translational modifications in dominantly inherited frontotemporal dementias: FTLD-TDP Type A (GRN) vs Type B (C9orf72).
    Cracco L; Doud EH; Hallinan GI; Garringer HJ; Jacobsen MH; Richardson RM; Buratti E; Vidal R; Ghetti B; Newell KL
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12836. PubMed ID: 35836354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
    Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
    Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration.
    Lee EB; Porta S; Michael Baer G; Xu Y; Suh E; Kwong LK; Elman L; Grossman M; Lee VM; Irwin DJ; Van Deerlin VM; Trojanowski JQ
    Acta Neuropathol; 2017 Jul; 134(1):65-78. PubMed ID: 28130640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia.
    Fontana E; Bongianni M; Benussi A; Bronzato E; Scialo C; Sacchetto L; Cagnin A; Castriciano S; Buratti E; Gardoni F; Italia M; Schreiber A; Ferracin C; Fiorini M; Newell KL; Cracco L; Garringer HJ; Cecchini MP; Polymenidou M; Padovani A; Monaco S; Legname G; Ghetti B; Borroni B; Zanusso G
    Alzheimers Dement; 2024 Feb; 20(2):1156-1165. PubMed ID: 37908186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.
    Buciuc M; Martin PR; Tosakulwong N; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
    Neuroimage Clin; 2022; 34():102954. PubMed ID: 35168140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.
    Foulds PG; Davidson Y; Mishra M; Hobson DJ; Humphreys KM; Taylor M; Johnson N; Weintraub S; Akiyama H; Arai T; Hasegawa M; Bigio EH; Benson FE; Allsop D; Mann DM
    Acta Neuropathol; 2009 Nov; 118(5):647-58. PubMed ID: 19823856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes.
    Pasquini L; Pereira FL; Seddighi S; Zeng Y; Wei Y; Illán-Gala I; Vatsavayai SC; Friedberg A; Lee AJ; Brown JA; Spina S; Grinberg LT; Sirkis DW; Bonham LW; Yokoyama JS; Boxer AL; Kramer JH; Rosen HJ; Humphrey J; Gitler AD; Miller BL; Pollard KS; Ward ME; Seeley WW
    Brain; 2024 Sep; 147(9):3032-3047. PubMed ID: 38940350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.